Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters. (Q45361615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Chun-Jen Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Tung-Hung Su

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jia-Horng Kao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

7

Pei-Jer Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

Chi-Ling Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Chia-Chi Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Stephanie Fang-Tzu Kuo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ding-Shinn Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

17 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

Journal of Infectious Diseases

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

54-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095766%20AND%20SRC:MED&resulttype=core&format=json

Global control of hepatitis B virus infection.

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687

Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR687